What are the potential complications of tricuspid annuloplasty?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Complications of Tricuspid Annuloplasty

The primary complications of tricuspid annuloplasty include residual or recurrent tricuspid regurgitation (10-35% at 5 years depending on technique), right ventricular failure, major bleeding, pericardial effusion, conduction abnormalities requiring permanent pacemaker, and device-specific complications. 1

Immediate Postoperative Complications

Cardiac Complications

  • Right ventricular failure: The most critical early complication, particularly in patients with severe preoperative RV dysfunction or irreversible pulmonary hypertension 1, 2
  • Residual tricuspid regurgitation: Occurs in 12.4% of patients immediately post-repair, with moderate TR in 11.7% and severe TR in 0.7% 3
  • Low cardiac output syndrome: Reported in approximately 11% of patients 4
  • Pericardial effusion: A recognized complication requiring monitoring 1

Bleeding and Vascular Complications

  • Major bleeding requiring reoperation: Occurs in approximately 11% of cases 4
  • Vascular complications: Standard surgical risks 1

Conduction Abnormalities

  • Atrioventricular block and pacemaker requirement: Tricuspid ring annuloplasty is an independent predictor of pacemaker requirement (OR: 2.348; 95% CI: 1.165-4.730) 5
  • Most patients requiring pacing (54.2%) need it for atrioventricular block 5
  • Cumulative pacemaker implantation rate is 6.4% at 50 days postoperatively 5

Other Early Complications

  • Acute kidney injury: Occurs in approximately 16% of patients 4
  • Operative mortality: Ranges from 6-9.1% depending on patient selection and comorbidities 4, 6

Late Complications and Failure Patterns

Recurrent Tricuspid Regurgitation

This is the most common long-term complication, with significant variation based on technique and patient factors:

  • Prosthetic ring annuloplasty: 10% recurrence at 5 years 7
  • Suture annuloplasty (De Vega): 20-35% recurrence at 5 years 7
  • 10-year freedom from grade ≥2+ TR: 77.8% (95% CI: 74.2%-81.4%) 6

Risk Factors for Late Failure

Preoperative anatomical factors:

  • Tricuspid annular diameter >40 mm (independent predictor, p=0.001) 6
  • TV coaptation depth ≥6.5 mm 3
  • Tenting area ≥0.85 cm² 3
  • Tenting height (HR: 5.52,95% CI: 1.87-14.57, p=0.002) 8
  • Indexed TA diameter (HR: 1.43,95% CI: 1.10-1.87, p=0.008) 8

Patient-related factors:

  • Left ventricular ejection fraction <50% (p=0.027) 6
  • Severe preoperative TR (associated with moderate residual TR, p<0.01) 4
  • Use of De Vega annuloplasty versus ring annuloplasty (p=0.019) 6
  • Smaller body surface area (BSA ≤1.9 m²) with higher indexed TA diameter 8

New left-sided valvular lesions:

  • Strong association with recurrent TR (OR: 5.3, p<0.0001), primarily mitral regurgitation 6

Reoperation Risks

Reoperation on the tricuspid valve after initial mitral valve surgery carries exceptionally high risk 7:

  • Perioperative mortality: 10-25% 2
  • Poor long-term results related to:
    • Irreversible RV dysfunction present before reoperation
    • Patient age and number of previous cardiac interventions
    • LV, myocardial, or valvular dysfunction 7

Long-Term Survival

Ten-year survival ranges from 30-50%, with predictors including 7:

  • Preoperative functional class
  • LV and RV function
  • Prosthetic complications

Critical Clinical Pitfalls

Timing-Related Issues

Operating too late is a major pitfall: Delaying surgery until severe RV dysfunction or end-organ damage develops leads to poor outcomes even with technically successful repair 7, 2. The guidelines emphasize early intervention before irreversible RV damage occurs.

Technical Considerations

  • Undersizing is crucial: Using size 26 or 28 rigid 3D annuloplasty rings achieves 97% freedom from significant TR at discharge 9
  • Ring type matters: Rigid or semi-rigid rings have superior outcomes compared to flexible bands or suture techniques 7

Patient Selection Errors

Severe RV dysfunction or irreversible pulmonary hypertension increases the risk of RV failure after operation, requiring careful risk-benefit assessment 2

Body Size Considerations

Smaller patients (BSA ≤1.9 m²) have higher TR recurrence rates (20.2% vs 6.5% at 5 years) when absolute TA diameter criteria are used, suggesting need for indexed measurements 8

Device-Specific Complications

While specific device complications are mentioned in guidelines 1, the evidence shows that ring-related complications such as ring dehiscence are rare when proper technique is used 4. However, the choice between ring types significantly impacts long-term durability.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.